Preferred Name |
atenolol |
|
Synonyms |
|
|
Definitions |
A synthetic isopropylamino-propanol derivative used as an antihypertensive, hypotensive and antiarrhythmic. Atenolol acts as a peripheral, cardioselective beta blocker specific for beta-1 adrenergic receptors, without intrinsic sympathomimetic effects. It reduces exercise heart rates and delays atrioventricular conduction, with overall decreasing oxygen requirements. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C28836" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C28836" NCI Thesaurus) |
|
ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000590657 |
|
CAS Registry |
29122-68-7 |
|
cui |
C0004147 |
|
DATE FIRST PUBLISHED |
2008-03-20 |
|
Date last modified |
2010-11-01 |
|
definition |
A synthetic isopropylamino-propanol derivative used as an antihypertensive, hypotensive and antiarrhythmic. Atenolol acts as a peripheral, cardioselective beta blocker specific for beta-1 adrenergic receptors, without intrinsic sympathomimetic effects. It reduces exercise heart rates and delays atrioventricular conduction, with overall decreasing oxygen requirements. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C28836" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C28836" NCI Thesaurus) |
|
NCI ID |
C28836 |
|
notation |
CDR0000590657 |
|
ORIG STY |
Drug/agent |
|
prefLabel |
atenolol |
|
tui |
T109 T121 |